The Rare Inherited Metabolic Disorders Drug market was valued at USD 217.80 Million in 2025 and is expected to reach USD 530.10 Million by 2033, growing at a CAGR of 11.8% (2025-2033). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.